切换至 "中华医学电子期刊资源库"
高级检索
中华肺部疾病杂志(电子版)

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (04) : 458 -462. doi: 10.3877/cma.j.issn.1674-6902.2019.04.011

论著

益生菌制剂在老年肺炎患者治疗中的临床应用
胡明1,†(), 李晓莉1, 甄鹏1, 陈亚利1, 沈宝征1   
  1. 1. 101100　通州，首都医科大学附属北京潞河医院感染性疾病科
  • 收稿日期:2018-07-10 出版日期:2019-08-20
  • 通信作者: 胡明
  • 基金资助:
    益生菌制剂用于老年肺炎治疗的临床研究(KJ2018CX009-33)

Clinical effect and prognosis of probiotics in treatment of senile pneumonia

Ming Hu1,†(), Xiaoli Li1, Peng Zhen1, Yali Chen1, Baozheng Shen1   

  1. 1. Department of Infectious Diseases, Beijing Luhe Hospital, Capital Medical University, Tongzhou 101100, China
  • Received:2018-07-10 Published:2019-08-20
  • Corresponding author: Ming Hu
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

胡明, 李晓莉, 甄鹏, 陈亚利, 沈宝征. 益生菌制剂在老年肺炎患者治疗中的临床应用[J]. 中华肺部疾病杂志(电子版), 2019, 12(04): 458-462.

Ming Hu, Xiaoli Li, Peng Zhen, Yali Chen, Baozheng Shen. Clinical effect and prognosis of probiotics in treatment of senile pneumonia[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(04): 458-462.

目的

探讨益生菌制剂对老年肺炎患者治疗的临床效果及预后。

方法

选取2016年8月至2018年8月在北京潞河医院收治的124例老年肺炎患者作为研究对象，按照简单随机法分为对照组64例，观察组60例；对照组予以肺炎标准治疗；观察组予以肺炎标准治疗+益生菌制剂。比较两组患者治疗前后腹泻情况、粪便pH值及住院时间，治疗效果，以及菌群失调、真菌感染、再次呼吸道感染、发热发生情况。

结果

观察组患者治疗后腹泻发生率、粪便pH值低于对照组(P<0.05)；对照组患者平均住院时间为(14.62±3.69)d，观察组患者平均住院时间为(10.35±3.11)d，观察组患者住院时间低于对照组(P<0.05)。两组患者治疗有效率分别为75.00%、90.00%，观察组治疗有效率高于对照组(P<0.05)。两组患者治疗前粪便涂片提示：细菌杆球比均≥3︰1、细菌总数为每油镜视野501～5 000个、无真菌感染；观察组患者住院期间、出院后30 d内菌群失调发生率低于对照组(P<0.05)；观察组患者出院后30 d内真菌感染发生率低于对照组(P<0.05)。对两组患者随访30 d，对照组患者发生呼吸道感染16例，发热14例，观察组患者发生呼吸道感染7例，发热4例；观察组患者呼吸道感染、发热发生率低于对照组，二组比较具有统计学差异(P<0.05)。

结论

益生菌制剂应用于老年肺炎患者治疗，可提高治疗效果，降低腹泻、菌群失调发生率，缩短住院时间，改善预后。

关键词: 益生菌制剂, 老年肺炎, 治疗效果, 预后
Objective

To explore the clinical effect and prognosis of probiotics in the treatment of senile pneumonia.

Methods

From August 2016 to August 2018, 124 elderly patients with pneumonia admitted to our hospital were selected as the research objects. They were divided into two groups according to the simple random method. The control group was given standard treatment of pneumonia, while the observation group was given standard treatment of pneumonia plus probiotics. The occurrence of diarrhea, fecal pH value, hospitalization time, therapeutic effect, bacterial imbalance, fungal infection, respiratory tract infection and fever were compared between the two groups before and after treatment.

Results

The incidence of diarrhea and the fecal pH value in the observation group were lower than those in the control group (P<0.05). The average periods of hospital stay were (14.62±3.69) days in the control group and (10.35±3.11) days in the observation group, which had statistical significant difference (P<0.05). The effective rates of treatment were 75.00% in the control group and 90.00% in the observation group, which had significant difference (P<0.05). The smear of the two groups before treatment showed that the ratio of bacteria to the ball was ≥3︰1, the total number of bacteria was 501-5 000 per oil field vision, and no fungal infection was found. Dysbacteriosis occurred in the two groups during hospitalization and within 30 days after discharge, however, the incidence was lower in the observation group than in the control group (P<0.05). The incidence of fungal infection in the observation group was lower than that in the control group within 30 days after discharge (P<0.05). The patients in the two groups were followed up for 30 days. In the control group, there were 16 cases of respiratory infection and 14 cases of fever. In the observation group, there were 7 cases of respiratory infection and 4 cases of fever. The incidence of respiratory infection and fever in the observation group was lower than that of the control group, which had statistical significant difference (P<0.05).

Conclusion

The application of probiotics in the treatment of senile pneumonia can improve the therapeutic effect, reduce the occurrence of diarrhea and dysbacteriosis, shorten the hospitalization time and improve the prognosis.

Key words: Probiotics, Elderly pneumonia, Therapeutic effect, Prognosis
表1 两组患者一般情况比较
组　别 例数 白细胞计数(×109/L) C反应蛋白(mg/L) 主要临床表现(例) 慢性病情况(例)
咳嗽 咳痰 发热 胸痛 高血压 冠心病 糖尿病 脑血管疾病
观察组 60 9.69±2.12 45.43±11.41 49 44 27 35 30 23 8 4
对照组 64 9.52±2.05 43.98±10.27 51 46 25 33 28 21 10 3
χ2/t值   0.9015 1.0681 1.2547 0.8306
P值   0.5732 0.4155 0.238 0.5107
表2 两组患者治疗前后腹泻发生情况、粪便pH值比较
组　别 例数 腹泻(例) 粪便pH值
治疗前 住院期间 治疗前 治疗后
对照组 64 0 9 5.37±0.26 6.60±0.48
观察组 60 0 2 5.41±0.21 5.64±0.42
χ2/t值     4.2573 0.7928 5.0167
P值   1.0000 0.0318 0.6159 0.0142
表3 两组患者治疗效果比较[n(%)]
组　别 例数 治愈 显效 进步 无效 有效率(%)
对照组 64 36(56.25) 12(18.75) 3(4.69) 13(20.31) 75.00
观察组 60 42(70.00) 12(20.00) 2(3.33) 4(6.67) 90.00
χ2值           4.1137
P值           0.0348
表4 两组患者治疗后肠道菌群失调发生情况[n(%)]
组　别 例数 菌群失调 真菌感染
住院期间 出院后30 d内 住院期间 出院后30 d内
对照组 64 13(20.31) 30(46.87) 0(0.00) 13(20.31)
观察组 60 4(6.67) 4(6.67) 0(0.00) 0(0.00)
t值   4.8031 6.1854   5.9125
P值   0.0317 0.0105 1.0000 0.0284
1
Viasus D, Núñez-Ramos JA, Viloria SA, et al. Pharmacotherapy for community-acquired pneumonia in the elderly[J]. Expert Opin Pharmacother, 2017, 18(10): 957.
2
黄　纯. 老年社区获得性肺炎治疗抗生素选择策略分析[J]. 内科，2016, 11(2): 262-264.
3
Su C, Liu Y, Zhang H, et al. Investigation of the Effects of Antibiotic Application on the Intestinal Flora in Elderly Hypertension Patients with Infectious Diseases[J]. Iran J Public Health, 2018, 47(3): 335.
4
Christophy R, Osman M, Mallat H, et al. Prevalence, antibiotic susceptibility and characterization of antibiotic resistant genes among carbapenem-resistant Gram-negative bacilli and yeast in intestinal flora of cancer patients in North Lebanon[J]. J Infect Public Health, 2017, 10(6): 716.
5
陈韦强，刘　漪，谢作舟. 老年重症肺炎降阶梯治疗对预后的影响[J]. 世界临床医学，2016, 10(1): 231-231.
6
中华医学会呼吸病学分会. 社区获得性肺炎诊断和治疗指南(草案)[J]. 中国实用乡村医生杂志，2006, 29(10): 651-655.
7
中华医学会呼吸病学分会. 社区获得性肺炎诊断和治疗指南[J]. 中国实用乡村医生杂志，2013, 29(2): 651-655.
8
《中华消化杂志》编委会，王兴鹏. 肠道菌群失调诊断治疗建议[J]. 中华消化杂志，2009, 29(5): 335-337.
9
Zhang S, Pang S, Wang P, et al. Antibiotic concentration and antibiotic-resistant bacteria in two shallow urban lakes after stormwater event[J]. Envir Sci Pollut Res Int, 2016, 23(10): 9984-9992.
10
Yosef I, Manor M, Qimron U. Counteracting selection for antibiotic-resistant bacteria[J]. Bacter, 2016, 6(1): e1096996.
11
Cheng H, Hong PY. Removal of Antibiotic-Resistant Bacteria and Antibiotic Resistance Genes Affected by Varying Degrees of Fouling on Anaerobic Microfiltration Membranes[J]. Envir Sci Technol, 2017, 51(21): 12200.
12
崔鹤仙，刘增辉，牛红梅，等. 68例老年轻中度肺部感染患者肠道菌群分析[J]. 实用心脑肺血管病杂志，2018, 26(3): 101-103.
13
赵玉爽，郑松柏. 肠道菌群演替及其影响因素研究进展[J]. 实用老年医学，2018, 32(5): 9-13.
14
Changhai SU, Liu Y, Zhang H, et al. Investigation of the Effects of Antibiotic Application on the Intestinal Flora in Elderly Hypertension Patients with Infectious Diseases[J]. Iran J Public Health, 2018, 47(3): 335.
15
白志余，庞桂芬，胡晓蕴，等. 肠道、肺部菌群直接或通过肠-肺轴对呼吸系统慢性疾病的影响[J]. 中国微生态学杂志，2018, 30(9): 105-109.
16
王丽娜，周旭春. 肠道菌群与肠黏膜免疫及相关肠道疾病的研究进展[J]. 中国微生态学杂志，2017, 29(4): 494-496.
17
李伟然，汪志凌，万朝敏. 肠道菌群与"肠-肺"轴之间的关系[J]. 中华实用儿科临床杂志，2017, 32(7): 548-551.
28
Wagener S, Schulz S, Hanselmann K. Abundance and distribution of anaerobic protozoa and their contribution to methane production in Lake Cadagno (Switzerland)[J]. Fems Microbiol Lett, 2017, 74(1): 39-48.
29
Fenchel T, Finlay BJ. Endosymbiotic Methanogenic Bacteria In Anaerobic Ciliates: Significance For the Growth Efficiency of the Host[J]. J Eukaryotic Microbiol, 2010, 38(1): 18-22.
30
刘松珍，张雁，张名位，等. 肠道短链脂肪酸产生机制及生理功能的研究进展[J]. 广东农业科学，2013, 40(11): 99-103.
18
葛文翠，刘　丽. 老年人抗生素相关性菌群失调分析[J]. 转化医学电子杂志，2016, 3(3): 55-58.
19
殷楠楠. 肠道菌群失调在临床中的研究[J]. 中国医药指南，2017, 15(05): 133-134.
20
Haiyan, Weiqiang, Huang, et al. The effects of probiotics administration on the milk production, milk components and fecal bacteria microbiota of dairy cows[J]. Sci Bull, 2017, 62(11): 767-774.
21
Noh CK, Kim BS, Hong G, et al. Effects of the Administration of Probiotics on Fecal Microbiota Diversity and Composition in Healthy Individuals[J]. J Neurogastroent Motil, 2018, 24(3): 452-459.
22
司继刚，孙　敏. 微生态制剂在防治抗菌药物相关性腹泻中的应用[J]. 中国药房，2014, 25(38): 3624-3627.
23
王　威，岳　妍，郝莉莉，等. 微生态制剂治疗抗生素相关性腹泻临床研究[J]. 中华医院感染学杂志，2016, 26(6): 1258-1260.
24
石朝积，冉春艳，吴兴文，等. 肠内营养联合益生菌减少呼吸机相关性肺炎的价值分析[J]. 医学研究与教育，2017, 34(3): 1-5.
25
闫　翔，李　钰，刘　芳，等. 微生态制剂预防老年抗生素相关性腹泻的临床研究[J]. 中国微生态学杂志，2013, 25(8): 936-938.
26
Horie H, Ito I, Konishi S, et al. Isolation of ESBL-producing Bacteria from Sputum in Community-acquired Pneumonia or Healthcare-associated Pneumonia Does Not Indicate the Need for Antibiotics with Activity against This Class[J]. Int Med, 2018, 57(4): 487-495.
27
李　娜，蒋林伟，张伟浩，等. 用益生菌制剂对重症肺炎患者进行辅助治疗的效果探析[J]. 当代医药论丛，2016, 14(20): 100-102.
[1] 马中正, 杨云川, 马翔, 周迟, 丁丁, 霍俊一, 徐楠, 崔培元, 周磊. 胰腺癌双硫死亡相关的lncRNA预后模型的构建及免疫反应研究[J]. 中华普通外科学文献(电子版), 2024, 18(05): 368-376.
[2] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[3] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[6] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[7] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[8] 袁庆港, 刘理想, 张亮, 周世振, 高波, 丁超, 管文贤. 尿素-肌酐比值（UCR）可预测结直肠癌患者术后的长期预后[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 506-509.
[9] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[10] 肖丹, 陈辰, 查晔军, 公茂琪, 花克涵, 孙伟桐, 蒋协远. 改良松解术治疗创伤后肘关节僵硬的疗效及危险因素分析[J]. 中华老年骨科与康复电子杂志, 2024, 10(05): 257-263.
[11] 唐诗, 薛传优, 叶兴, 张鸿举, 戴瑞. 急性病毒性肝炎患者血脂、血糖、蛋白、尿酸变化特点及其与预后的关联[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 396-399.
[12] 李素娟, 王文玲, 董洪敏, 李小凯, 黄思成, 王刚. 多原发与单原发大肠腺癌的预后分析[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 407-412.
[13] 孙文恺, 沈青, 杭丽, 张迎春. 纤维蛋白原与清蛋白比值、中性粒细胞与白蛋白比值、C反应蛋白与溃疡性结肠炎病情评估和预后的关系[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 426-431.
[14] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
[15] 闫战涛, 王辉, 周梓迪, 史勇强, 陈铜兵. 胃淋巴上皮瘤样癌三级淋巴结构特征及其与预后的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 455-461.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号